Therapeutic Goods Administration to approve NSW medicinal cannabis access
The NSW Government is improving access to medicinal cannabis by using a Commonwealth Therapeutic Goods Administration (TGA) assessment to approve access for patients.
A single application process to the TGA will replace separate approvals from the Commonwealth and NSW Health.
Strong safeguards are in place for patients to access medicinal cannabis.
NSW Minister for Health and Medical Research Brad Hazzard said the new approach is more compassionate.
“A single approval process enables a focus on the world-leading clinical trials under the NSW Government’s $21 million invested into medicinal cannabis,” Mr Hazzard said.
“We are committed to supporting doctors wanting to prescribe medicinal cannabis.”
The new arrangement will start in the coming weeks.